CHRS Analyst Ratings 2026

Coherus Oncology Inc - Wall Street recommendations & price targets

Consensus Rating

N/A

Current Price

$1.99

Get Complete CHRS Analysis

AI insights, DCF valuation, and institutional ownership

View Full Analysis

Frequently Asked Questions

What is the analyst rating for CHRS?

Analyst rating data for CHRS is being updated. Check back for the latest Wall Street recommendations.

What is the CHRS price target?

Price target data for CHRS is being updated.

Is CHRS a buy according to analysts?

Check the latest analyst recommendations for CHRS.

How many analysts cover CHRS?

Analyst coverage information for CHRS is being updated.

Explore Categories